Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Marseille
Clinical trial register · France

Clinical Trials in Marseille, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9730 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:21 UTC
9730
Studies in scope
all four open statuses
6053
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2848 Lyon 1396 Bordeaux 1393 Marseille 1288 Lille 1272

Trials with a site in Marseille

1288 of 9730 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Marseille, Besançon, Brest, Toulouse, Limoges, La Tronche, Orléans, Lille
2021-04-21
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
140
Amiens, Angers, Bordeaux, Dijon, Grenoble, Lille, Lyon, Marseille
2021-04-16
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
7
Marseille
2021-04-16
Recruiting
ModernaTX, Inc.
Phase 1/2
77
Marseille, Paris
2021-04-15
Active, closed
IDEAYA Biosciences
Phase 1
169
Bordeaux, Toulouse, Marseille, Dijon, Rennes, Villejuif
2021-04-14
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC
Phase 2
490
Nice, Pierre-Bénite, Marseille, Le Chesnay, Paris
2021-04-05
Active, closed
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT03915678Solid Tumor, Adult, Pancreatic Cancer, Virus-associated Tumors, Non Small Cell Lung Cancer
Institut Bergonié
Phase 2
247
Bordeaux, Brest, Caen, Dijon, Lille, Marseille, Paris, Poitiers
2021-03-31
Recruiting
Molecular Signature From Tumor to Lymph Nodes
NCT04677205Lung Cancer, Stage IIIA-cN2, Operated With Curative Intent, Primary Tumor Tissue Available
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Clamart, Marseille, Nice, Paris, Rennes, Strasbourg, Toulouse
2021-03-30
Recruiting
Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors
NCT04520932Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1
Institut Paoli-Calmettes
Not applicable
82
Marseille
2021-03-30
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Brest, Marseille, Nice, Paris, Villejuif
2021-03-22
Recruiting
Calico Life Sciences LLC
Phase 1
248
Marseille, Toulouse, Nice, Suresnes
2021-03-09
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
200
Angers, Bordeaux, Brest, Lille, Limoges, Lyon, Marseille, Montpellier
2021-03-06
Active, closed
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Phase 3
455
Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Paris
2021-02-25
Active, closed
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT04699188KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung
Novartis Pharmaceuticals
Phase 1/2
344
Lyon, Marseille, Villejuif
2021-02-24
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Brest, Bron, Le Kremlin-Bicêtre, Lille, Marseille
2021-02-23
Active, closed
University Hospital, Montpellier
Phase 2
202
Amiens, Angers, Bondy, Clichy, Dijon, Grenoble, Lille, Marseille
2021-02-23
Active, closed
AbbVie
Phase 1
81
Marseille, Bordeaux, Paris, Dijon, Toulouse
2021-02-23
Recruiting
Biosense Webster, Inc.
Observational
8,000
Clermont-Ferrand, Lyon, Marseille, Paris, Rennes, Strasbourg, Talence
2021-02-22
Recruiting
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
NCT04545502Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection
Vascutek Ltd.
Observational
2,000
Bordeaux, Clermont-Ferrand, Dijon, Lille, Marseille, Rennes, Strasbourg, Toulouse
2021-02-17
Recruiting
AB Science
Phase 3
495
Angers, Bordeaux, Bron, Clermont-Ferrand, Lille, Limoges, Marseille, Montpellier
2021-02-02
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
Artios Pharma Ltd
Phase 1/2
542
Villejuif, Paris, Poitiers, Bordeau, Marseille
2021-01-27
Recruiting
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
NCT04248283Urinary Incontinence, Urinary Incontinence,Stress
Uromedica
Not applicable
167
Marseille, Nantes, Paris
2021-01-26
Active, closed
Hoffmann-La Roche
Phase 2
920
Bordeaux, Lille, Lyon, Marseille, Toulouse, Villejuif
2021-01-18
Active, closed
Genmab
Phase 3
483
Amiens, Bayonne, Brest, Caen, La Rochelle, Limoges, Lyon, Marseille
2021-01-13
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
126
Amiens, Bobigny, Bordeaux, Boulogne-Billancourt, Colombes, Créteil, Lille, Marseille
2021-01-07
Active, closed
BioNTech SE
Phase 2/3
358
Bordeaux, Caen, Dijon, Marseille, Paris, Tours, Villejuif
2021-01-07
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
78
Amiens, Besançon, Clichy, Dijon, Lyon, Marseille, Paris, Pessac
2021-01-05
Active, closed
Daiichi Sankyo
Phase 3
605
Besançon, Grenoble, Lyon, Marseille, Nantes, Paris, Poitiers, Rennes
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bordeaux, Grenoble, Hyères, Limoges, Lyon, Marseille, Montpellier, Nîmes
2020-12-18
Recruiting
Teknimed
Observational
1,050
Brive-la-Gaillarde, Aubenas, Écully, Évreux, Puilboreau, Coutances, Boujan-sur-Libron, Marseille
2020-12-16
Recruiting
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NCT04342546Breast Cancer, Capsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
250
Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain
2020-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Saint-Quentin, Bordeaux, Marseille, Grenoble, Saint-Herblain, Angers, Bobigny, Toulon
2020-12-08
Active, closed
Amgen
Phase 3
135
Clichy, Lille, Marseille, Nantes, Pessac
2020-12-04
Recruiting
Ovarian Reserve and Bariatric Surgery
NCT04583150Bariatric Surgery, Obesity, Reproductive Health, Fertility
Assistance Publique - Hôpitaux de Paris
Observational
238
Angers, Clermont-Ferrand, Colombes, Dijon, Grenoble, Lille, Lyon, Marseille
2020-12-03
Active, closed
Eli Lilly and Company
Phase 3
312
Amiens, Bordeaux, Créteil, Lille, Marseille, Paris
2020-11-25
Active, closed
Science Corporation
Not applicable
38
Lyon, Bordeaux, Créteil, Marseille, Nantes, Paris
2020-11-24
Recruiting
Alnylam Pharmaceuticals
Observational
1,500
Bordeaux, Bron, Créteil, Le Kremlin-Bicêtre, Marseille
2020-11-23
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
Eli Lilly and Company
Phase 1
260
Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2020-11-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
300
Angers, Caen, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2020-11-11
Active, closed
Genmab
Phase 1/2
543
Lille, Marseille, Paris, Pierre-Bénite
2020-11-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Caen, Créteil, Dijon, Lille, Limoges, Marseille, Paris, Pessac
2020-11-03
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 4
60
Nice, Marseille
2020-11-02
Active, closed
Hoffmann-La Roche
Phase 1/2
518
Dijon, Marseille, Rennes, Villejuif
2020-11-01
Active, closed
Novartis Pharmaceuticals
Phase 2
134
Lille, Marseille, Paris, Pierre-Bénite, Toulouse, Villejuif
2020-10-30
Recruiting
Institut Claudius Regaud
Phase 3
600
Besançon, Caen, Clermont-Ferrand, Dijon, Limoges, Lyon, Marseille, Montpellier
2020-10-09
Active, closed
Acerta Pharma BV
Phase 3
611
Brest, Caen, Marseille, Montpellier, Nantes, Pessac, Pierre-Bénite, Rennes
2020-10-08
Active, closed
CARdiomyopathy in Type 2 DIAbetes Mellitus
NCT04303364Cardiomyopathy, Diabetic
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,256
Bron, Créteil, Grenoble, Marseille, Nantes, Paris
2020-10-02
Active, closed
AstraZeneca
Phase 3
370
Avignon, Bordeaux, Clermont-Ferrand, Dijon, Lyon, Marseille, Montpellier, Strasbourg
2020-10-02
Active, closed
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
NCT04093349Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2, Glycogen Storage Disease Type II
Spark Therapeutics, Inc.
Phase 1/2
4
Angers, Garches, Lille, Marseille, Nice
2020-10-01
Active, closed
GlaxoSmithKline
Phase 3
302
Marseille, Toulouse, Vanduvre-lEs-Nancy
2020-10-01
Active, closed
AbbVie
Phase 3
527
Nice, Clermont, Marseille, Pessac, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bordeaux, Bron, La Tronche, Lille, Limoges, Marseille, Paris, Pessac
2020-09-30
Active, closed
University of Zurich
Not applicable
986
Dijon, Lyon, Marseille, Nice, Toulouse
2020-09-30
Recruiting
University Hospital, Toulouse
Phase 2
32
Grenoble, Lille, Marseille, Montpellier, Nantes, Poitiers, Toulouse
2020-09-22
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
PREdiction of Chronic LUng Allograft Dysfunction
NCT03967340Lung Transplant Rejection
Nantes University Hospital
Observational
240
Bordeaux, Grenoble, Le Plessis-Robinson, Lyon, Marseille, Nantes, Paris, Strasbourg
2020-09-10
Active, closed
Institut Paoli-Calmettes
Phase 2
124
Marseille
2020-09-07
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Toulouse, Dijon, Lille, Lyon, Marseille, Saint-Herblain, Villejuif
2020-09-03
Active, closed
Philogen S.p.A.
Phase 2
98
Besançon, Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Toulouse, Villejuif
2020-08-28
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Caen, Créteil, Limoges, Marseille, Paris, Pessac, Pierre-Bénite, Poitiers
2020-08-25
Recruiting
Assistance Publique Hopitaux De Marseille
Phase 1
54
Marseille
2020-08-03
Active, closed
AstraZeneca
Phase 3
866
Avignon, Besançon, Bordeaux, Brest, Caen, Dijon, Le Mans, Marseille
2020-07-24
Recruiting
University Hospital, Toulouse
Phase 3
310
Bordeaux, Clermont-Ferrand, Créteil, Marseille, Pierre-Bénite, Poitiers, Saint-Herblain, Saint-Pierre
2020-07-17
Active, closed
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms
BicycleTx Limited
Phase 1/2
329
Bordeaux, Lyon, Marseille, Rennes, Villejuif
2020-07-17
Active, closed
AstraZeneca
Phase 3
1,012
Besançon, Bordeaux, Marseille, Montpellier, Nice, Paris, Pierre-Bénite, Quimper
2020-07-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Marseille, Brest, Epagny Metz Tessy, Valenciennes, Bobigny, Amiens, Toulon, La Roche-sur-Yon
2020-07-06
Recruiting
Jules Bordet Institute
Not applicable
600
Lille, Marseille, Paris, Rouen, Strasbourg, Toulouse
2020-07-01
Recruiting
Butyrophilins Role in Colon Cancer
NCT04185272Colonic Cancer
Institut Paoli-Calmettes
Not applicable
200
Marseille
2020-06-30
Active, closed
Actelion
Phase 3
935
Brest, Caen, Le Kremlin-Bicêtre, Lille, Marseille, Nice, Saint-Priest-en-Jarez, Toulouse
2020-06-30
Recruiting
Institut Paoli-Calmettes
Observational
39
Marseille
2020-06-08
Recruiting
Centre Antoine Lacassagne
Phase 2
103
Bordeaux, Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2020-06-04
Recruiting
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases
Drahomir Aujesky
Phase 4
276
Le Kremlin-Bicêtre, Brest, Clermont-Ferrand, Dijon, Lyon, Marseille, Rouen, Saint-Priest-en-Jarez
2020-05-15
Active, closed
Assistance Publique Hopitaux De Marseille
Observational
40
Marseille
2020-04-21
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
Turning Point Therapeutics, Inc.
Phase 1/2
75
Lyon, Angers, Bordeaux, Marseille, Nantes, Paris, Villejuif
2020-03-12
Active, closed
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
NCT04987528Severe Acute Respiratory Syndrome Coronavirus 2, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
Hôpital Européen Marseille
Observational
200
Marseille
2020-03-11
Active, closed
First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company
Phase 1/2
293
Bordeaux, Lyon, Marseille, Nantes, Nice, Paris, Poitiers
2020-03-05
Recruiting
Centre Leon Berard
Not applicable
168
Besançon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Paris, Poitiers
2020-03-03
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Lyon, Lille, Montpellier, Toulouse, Marseille, Nice, Paris
2020-02-25
Recruiting
Assistance Publique Hopitaux De Marseille
Phase 2
84
Marseille
2020-02-19
Active, closed
Eli Lilly and Company
Phase 3
261
Lyon, Marseille, Montpellier, La Tronche, Clermont-Ferrand, Paris
2020-02-17
Recruiting
Hospices Civils de Lyon
Phase 1/2
26
Pierre-Bénite, Bordeaux, Caen, Lille, Marseille, Nice, Paris, Rennes
2020-02-12
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Strasbourg, Bordeaux, Lyon, Marseille, Caen, Dijon, Toulouse, Angers
2020-02-11
Active, closed
Daiichi Sankyo
Phase 1
115
Bordeaux, Créteil, Marseille, Marsielle, Poitiers, Toulouse, Villejuif
2020-02-10
Recruiting
Assistance Publique Hopitaux De Marseille
Phase 1/2
20
Marseille
2020-02-05
Recruiting
Centre Leon Berard
Phase 2
455
Angers, Bordeaux, Caen, Lyon, Marseille, Nice, Paris, Rouen
2020-01-28
Active, closed
Actelion
Phase 3
138
Lille, Marseille, Montpellier, Paris, Pessac, Toulouse
2020-01-16
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Lille, Lyon, Marseille, Paris
2020-01-05
Recruiting
Natural History of Duchenne Muscular Dystrophy
NCT03882827Duchenne Muscular Dystrophy
Genethon
Observational
220
Bordeaux, Brest, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2019-12-19
Active, closed
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
NCT04183166Squamous Cell Carcinoma of Head and Neck
Transgene
Phase 1/2
80
Bordeaux, Marseille, Paris, Toulouse, Villejuif
2019-12-12
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Créteil, Marseille, Paris, Toulouse
2019-11-26
Active, closed
AbbVie
Phase 1/2
218
Marseille, Toulouse, Paris, Nice, Pierre-Bénite, Le Chesnay
2019-11-06
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
Novartis Pharmaceuticals
Phase 4
163
Rennes, Brest, Marseille, Paris, Vandœuvre-lès-Nancy, Villejuif
2019-11-04
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Lille, Lyon, Marseille, Villejuif
2019-10-30
Active, closed
AstraZeneca
Phase 3
140
Dijon, Marseille, Montpellier, Nantes, Paris, Suresnes, Toulouse
2019-10-29
Recruiting
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
NCT04104529Thyroid Cancer, Prostate Cancer, Neuroendocrine Tumors, SSTR Positive Tumors
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
350
Bordeaux, Marseille, Montpellier, Toulouse
2019-10-28
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Recruiting
GlaxoSmithKline
Phase 1/2
184
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Toulouse
2019-10-25
Recruiting
University Hospital, Lille
Observational
447
Angers, Besançon, Bondy, Caen, La Tronche, Lille, Marseille, Montpellier
2019-10-23
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
Replimune, Inc.
Phase 2
231
Besançon, Dijon, La Tronche, Lille, Lyon, Marseille, Nice, Paris
2019-10-08
Recruiting
Hôpital Européen Marseille
Observational
60
Marseille
2019-10-08
Active, closed
Assistance Publique Hopitaux De Marseille
Phase 1
32
Marseille
2019-09-30
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
220
Issy-les-Moulineaux, Le Plessis-Robinson, Limoges, Marseille, Neuilly-sur-Seine, Paris
2019-09-30
Active, closed
RECORDATI GROUP
Observational
125
Lille, Marseille, Villejuif
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Bordeaux, Lyon, Marseille, Paris, Poitiers, Saint-Mandé, Villejuif
2019-09-04
Active, closed
BeOne Medicines
Phase 3
510
Bordeaux, Brest, Dijon, Grenoble, Le Mans, Lille, Marseille, Nantes
2019-08-20
Recruiting
Unruptured Cerebral Aneurysm: Prediction of Evolution
NCT04578808Unruptured Intracranial Aneurysm
Nantes University Hospital
Observational
1,000
Marseille, Brest, Bordeaux, Toulouse, Limoges, Rennes, Tours, Nantes
2019-08-19
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene
Phase 3
665
Angers, Créteil, La Tronche, Lille, Marseille, Paris, Pessac, Pierre-Bénite
2019-08-12
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Bordeaux, Vandœuvre-lès-Nancy, Clermont-Ferrand, Créteil, Dijon, La Tronche, Lille, Marseille
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Limoges, Lille, Bayonne, Besançon, Lyon, Marseille, Montpellier, Nantes
2019-08-05
Recruiting
Global Coalition for Adaptive Research
Phase 2/3
2,250
Bron, Marseille, Paris
2019-07-30
Active, closed
OncoVerity, Inc.
Phase 2
103
Angers, Grenoble, Marseille, Pessac, Pierre-Bénite, Toulouse, Tours
2019-07-29
Active, closed
Novartis Pharmaceuticals
Phase 3
253
Créteil, Marseille, Paris
2019-07-26
Active, closed
Oxford BioTherapeutics Ltd
Phase 1
200
Marseille, Paris, Rennes, Strasbourg, Villejuif
2019-07-25
Recruiting
Hôpital Européen Marseille
Not applicable
80
Marseille
2019-07-16
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Angers, Bron, Dijon, Hellemmes-Lille, Marseille, Montpellier, Paris, Poitiers
2019-07-09
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
530
Marseille
2019-07-05
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
100
Marseille
2019-07-04
Active, closed
Novo Nordisk A/S
Phase 2
62
Angers, Le Kremlin-Bicêtre, Marseille, Marseille Cédex 05, Paris, Toulouse
2019-07-04
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Phase 1/2
218
Marseille, Paris, Pierre-Bénite, Rennes
2019-06-26
Active, closed
AstraZeneca
Phase 3
923
Brest, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain, Villejuif
2019-06-25
Active, closed
Eisai Inc.
Phase 2
100
Marseille, Bordeaux, Paris, Rennes, Toulouse
2019-05-31
Recruiting
Speckle Tracking Echocardiography for the Prediction of Weaning Failure
NCT03657524Weaning Failure of Mechanical Ventilation
Assistance Publique Hopitaux De Marseille
Not applicable
110
Marseille
2019-05-20
Active, closed
Institut Paoli-Calmettes
Observational
1,020
Marseille
2019-05-14
Active, closed
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
NCT03842982Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma
DrugHipec
Centre Oscar Lambret
Phase 3
362
Angers, Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris
2019-05-03
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Marseille, Nantes, Rennes, Tours
2019-04-26
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Marseille, Paris, Toulouse
2019-04-16
Active, closed
Eisai Inc.
Phase 3
1,906
Marseille, Montpellier, Nantes, Paris, Toulouse, Bron, Strasbourg
2019-03-27
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
Exelixis
Phase 1
325
Clermont, Saint-Herblain, Bordeaux, Caen, Marseille, Paris, Pierre-Bénite, Poitiers
2019-03-20
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
AstraZeneca
Phase 1/2
50
Lille, Marseille, Paris
2019-03-07
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Angers, Nice, Lille, Marseille, Villejuif
2019-02-28
Recruiting
Institut Bergonié
Phase 3
351
Bordeaux, Dijon, Limoges, Lyon, Marseille, Montpellier, Saint-Herblain, Strasbourg
2019-02-14
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bordeaux, Dijon, Lille, Lyon, Marseille, Paris, Poitiers, Saint-Herblain
2019-02-08
Recruiting
University Hospital, Tours
Observational
150
Bordeaux, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Rennes
2019-02-04
Recruiting
Centre Leon Berard
Phase 2
40
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lille, Limoges, Lyon, Marseille
2019-01-23
Recruiting
RECORDATI GROUP
Observational
95
Bordeaux, Marseille, Nancy, Paris, Rouen, Strasbourg
2019-01-15
Active, closed
Ancora Heart, Inc.
Not applicable
132
Pessac, Bron, Marseille, Paris, Strasbourg, Toulouse
2019-01-15
Active, closed
AstraZeneca
Phase 2
367
Dijon, Marseille, Nantes, Paris, Rennes
2019-01-09
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
Actuate Therapeutics Inc.
Phase 2
350
Besançon, Brest, Lille, Vandœuvre-lès-Nancy, Bordeaux, Saint-Herblain, Marseille
2019-01-04
Active, closed
AstraZeneca
Phase 3
1,407
Besançon, Bordeaux, Limoges, Lyon, Marseille, Nantes, Paris, Saint-Herblain
2019-01-04
Active, closed
Jules Bordet Institute
Phase 1/2
129
Besançon, Bordeaux, Dijon, Marseille, Nice, Paris, Poitiers, Rouen
2018-12-28
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
32
Marseille
2018-12-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Nice, Marseille, Toulouse, Villejuif, Avignon, Paris
2018-12-17
Not yet open
Assistance Publique Hopitaux De Marseille
Observational
165
Marseille
2018-11
Active, closed
IRCCS San Raffaele
Observational
200
Marseille, Paris
2018-10-30
Active, closed
UNICANCER
Phase 2
60
Amiens, Angers, Bordeaux, Caen, La Tronche, Lille, Lyon, Marseille
2018-10-23
Active, closed
AbbVie
Phase 2
270
Marseille, Bordeaux, Lille, Paris, Bron, Lyon, Créteil, Villejuif
2018-10-10
Active, closed
Exelixis
Phase 3
187
Dijon, Bordeaux, Angers, Marseille, Besançon, Lyon, Nice, Paris
2018-10-05
Active, closed
Hospices Civils de Lyon
Phase 3
108
Aix-en-Provence, Besançon, Bordeaux, Colmar, Lille, Lyon, Marseille, Paris
2018-10-02
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Bordeaux, Lyon, Marseille, Paris
2018-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Montpellier, Rennes, Angers
2018-09-12
Active, closed
AbbVie
Phase 3
1,242
Nice, Marseille, Montpellier, Vandœuvre-lès-Nancy, Pessac, Saint Priest EN Jarez, Amiens, Nantes
2018-08-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Nice, Strasbourg, Pessac, Pierre-Bénite, Lyon, Marseille, Caen, Dijon
2018-08-21
Recruiting
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
NCT03583710ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma
M.D. Anderson Cancer Center
Phase 3
240
Angers, Besançon, Brest, Dijon, Lyon, Marseille, Nantes, Paris
2018-08-20
Active, closed
Hoffmann-La Roche
Phase 3
257
Angers, Marseille, Paris, Villejuif
2018-08-16
Active, closed
Gilead Sciences
Phase 2
502
Besançon, Bordeaux, Brest, Clermont-Ferrand, La Roche-sur-Yon, Lille, Lyon, Marseille
2018-08-13
Active, closed
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Recruiting
Celgene
Phase 2/3
1,541
Creteil-Paris, Lille, Lyon, Marseille, Montpellier, Nantes, Paris, Pessac
2018-07-19
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
100
Marseille
2018-07-02
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Besançon, Bourgoin, Lyon, Marseille, Nantes, Pont-de-Vaux, Portes-lès-Valence, Suresnes
2018-06-25
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Observational
106
Villejuif, Créteil, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2018-06-22
Recruiting
Application of ihMT MRI in Multiple Sclerosis
NCT03600779Sclerosis, Multiple
Assistance Publique Hopitaux De Marseille
Not applicable
85
Marseille
2018-06-14
Active, closed
Hoffmann-La Roche
Phase 3
927
Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier
2018-05-28
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Brest, Caen, Chartres, Lomme, Lorient, Marseille, Massy, Melun
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,018
Amiens, Angers, Bordeaux, Lyon, Marseille, Montpellier, Strasbourg, Suresnes
2018-05-14
Active, closed
GlaxoSmithKline
Phase 2
237
Le Mans, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Genmab
Phase 1/2
560
Bordeaux, Lyon, Marseille, Montpellier, Nice, Paris, Rouen
2018-05-02
Active, closed
Centre Hospitalier Universitaire de Nīmes
Not applicable
300
Béziers, Bordeaux, Bron, Clermont-Ferrand, Créteil, Grenoble, Limoges, Marseille
2018-04-24
Active, closed
Hospices Civils de Lyon
Observational
670
Amiens, Angers, Bordeaux, Clichy, Dijon, Lille, Lyon, Marseille
2018-04-16
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
55
Brest, Bron, Caen, La Tronche, Marseille, Paris, Toulouse, Villejuif
2018-04-11
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Rennes, Amiens, Bordeaux, Lille, Marseille, Paris, Pierre-Bénite, Poitiers
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Lyon, Marseille, Bordeaux, Lille, Villejuif, Paris
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Angers, Bordeaux, Caen, La Rochelle, Lyon, Marseille, Paris, Strasbourg
2018-04-05
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
10
Marseille
2018-03-30
Active, closed
Orion Corporation, Orion Pharma
Phase 1/2
204
Bordeaux, Lyon, Marseille, Strasbourg, Suresnes, Villejuif
2018-03-19
Active, closed
AstraZeneca
Phase 2
273
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier
2018-03-07
Recruiting
FARD (RaDiCo Cohort) (RaDiCo-FARD)
NCT05954416Inherited Epidermolysis Bullosa, Ichthyosis, Ectodermal Dysplasia, Incontinentia Pigmenti
Institut National de la Santé Et de la Recherche Médicale, France
Observational
900
Bobigny, Bordeaux, Créteil, Dijon, Limoges, Marseille, Montpellier, Nice
2018-03-07
Recruiting
Centre Hospitalier Universitaire, Amiens
Phase 3
424
Amiens, Angers, Marseille
2018-02-05
Recruiting
Mucopolysaccharidosis VII Disease Monitoring Program
NCT03604835Mucopolysaccharidosis VII, MPS VII, MPS 7, Sly Syndrome
Ultragenyx Pharmaceutical Inc
Observational
50
Marseille
2018-01-29
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
Curis, Inc.
Phase 1/2
152
Bordeaux, Marseille, Paris
2017-12-28
Recruiting
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NCT02838602Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Hospices Civils de Lyon
Not applicable
250
Amiens, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon, Marseille
2017-12-23
Recruiting
Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years
NCT03463668Digestive or Non-digestive Neoplasia Leading to Symptomatic Duodenal Stenosis
Institut Paoli-Calmettes
Observational
200
Marseille
2017-12-22
Recruiting
MPS (RaDiCo Cohort) (RaDiCo-MPS)
NCT06036693Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis IV
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,000
Angers, Bordeaux, Brest, Clermont-Ferrand, Clichy, Garches, Lille, Marseille
2017-12-20
Recruiting
Institut Paoli-Calmettes
Observational
3,000
Marseille
2017-11-06
Active, closed
BeiGene
Phase 3
590
Argenteuil, Bordeaux, Caen, La Roche-sur-Yon, Le Mans, Limoges, Marseille, Nantes
2017-10-31
Active, closed
AstraZeneca
Phase 3
1,324
Clichy, Lille, Marseille, Montpellier, Nancy, Nantes, Nice, Pessac
2017-10-11
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
70
Marseille
2017-10-02
Recruiting
Apollomics Inc.
Phase 2
497
Brest, Lyon, Marseille, Paris, Villejuif
2017-09-27
Active, closed
Hoffmann-La Roche
Phase 3
382
Besançon, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite
2017-09-20
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
Replimune, Inc.
Phase 2
340
Besançon, Bordeaux, Dijon, Lyon, Marseille, Nice, Paris, Villejuif
2017-09-20
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
Transgene
Phase 1/2
143
Angers, Besançon, Bordeaux, Colmar, Dijon, Lyon, Marseille, Paris
2017-09-01
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Amiens, Bron, Lille, Marseille, Strasbourg
2017-08-23
Active, closed
Medtronic
Observational
1,092
Avignon, Bayonne, Brest, Caen, Clermont-Ferrand, Dijon, La Rochelle, Marseille
2017-08-21
Active, closed
Hoffmann-La Roche
Phase 2
316
Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Marseille, Nice, Paris, Poitiers
2017-06-27
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum
Phase 3
407
Amiens, Nîmes, Marseille, Paris, Pessac, Pierre-Bénite, Poitiers
2017-06-26
Active, closed
Institut Paoli-Calmettes
Not applicable
50
Marseille
2017-05-29
Active, closed
Eli Lilly and Company
Phase 1/2
857
Bordeaux, Lyon, Marseille, Montpellier, Villejuif, Paris
2017-05-02
Active, closed
Pfizer
Phase 3
296
Pessac, Chevilly-Larue, Le Mans, Marseille, Paris, Rennes, Suresnes, Toulouse
2017-04-27
Active, closed
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776Triple-Negative Breast Neoplasm
UNICANCER
Not applicable
149
Clermont-Ferrand, Dijon, Lyon, Marseille, Nantes, Rennes, Strasbourg, Vandœuvre-lès-Nancy
2017-04-14
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
200
Draguignan, Marseille, Nice, Ollioules
2017-04-12
Recruiting
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
NCT05945576Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, Transient Neonatal Diabetes Mellitus, Angelman Syndrome
Institut National de la Santé Et de la Recherche Médicale, France
Observational
2,000
Angers, Besançon, Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Limoges, Lyon, Marseille
2017-03-10
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Marseille, Brest, Dijon, Grenoble, Nice, Poitiers, Saint-Mandé, Villejuif
2017-03-07
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Marseille, Versailles
2017-02-08
Active, closed
The Netherlands Cancer Institute
Phase 3
174
Marseille, Paris
2017-01-25
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
300
Marseille
2017-01-17
Active, closed
Société Française d'Endoscopie Digestive
Observational
100
Amiens, Angers, Besançon, Bordeaux, Clichy, Dijon, Lyon, Marseille
2017-01-10
Active, closed
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT03305146Pancreatic Cyst, Pancreas Cyst, Serous Cystadenoma, Mucinous Cystadenoma
Hospital St. Joseph, Marseille, France
Not applicable
93
Charenton-le-Pont, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Vichy
2017-01
Active, closed
AstraZeneca
Phase 1
117
Bordeaux, Caen, Lyon, Marseille, Saint-Herblain, Toulouse
2016-12-28
Active, closed
UNICANCER
Phase 2
37
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Limoges, Lyon, Marseille
2016-10-17
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Villejuif, Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2016-08-03
Active, closed
Philogen S.p.A.
Phase 3
214
Marseille, Nantes, Villejuif
2016-07-01
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
80
Marseille, Montpellier
2016-06-06
Recruiting
Institut Bergonié
Not applicable
205
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Paris, Toulouse
2016-06
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Bordeaux, Dijon, Lyon, Marseille, Paris, Saint-Herblain, Villejuif
2016-05-24
Active, closed
NeuroDerm Ltd.
Phase 2
214
Aix-en-Provence, Amiens, Bron, Clermont-Ferrand, Lille, Marseille, Poitiers
2016-05-04
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
316
Marseille
2016-05
Active, closed
AstraZeneca
Phase 1/2
264
Bordeaux, Caen, Clermont-Ferrand, Dijon, Marseille, Nantes, Paris, Pierre Benit Cedex
2016-03-17
Active, closed
Tesaro, Inc.
Phase 1
729
Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Paris, Saint-Herblain, Villejuif
2016-03-07
Active, closed
MedImmune LLC
Phase 1/2
383
Marseille, Nantes
2016-02-22
Recruiting
University Hospital, Lille
Observational
85
Amiens, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2016-02-03
Recruiting
Institut Paoli-Calmettes
Observational
10,000
Marseille
2016-01-18
Active, closed
AbbVie
Phase 3
1,629
Toulouse, Lille, Montpellier, Bordeaux, Caen, Clermont-Ferrand, Marseille, Paris
2015-12-01
Active, closed
AstraZeneca
Phase 3
1,126
Bordeaux, Caen, Lyon, Marseille, Paris, Poitiers, Suresnes, Toulouse
2015-11-02
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Lyon, Marseille, Paris, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
2015-08-06
Active, closed
AstraZeneca
Phase 3
1,118
Bordeaux, Brest, Créteil, Lille, Lyon, Marseille
2015-07-21
Active, closed
Centre Antoine Lacassagne
Phase 3
148
Lyon, Besançon, Reims, Marseille, Mâcon, Nice, Pierre-Bénite, Saint-Priest-en-Jarez
2015-06-24
Recruiting
Centre Leon Berard
Phase 2/3
536
Strasbourg, Marseille, Dijon, Besançon, Brest, Bordeaux, Toulouse, Montpellier
2015-06-02
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Dijon, Lyon, Marseille, Nice, Paris, Saint-Etienne, Strasbourg, Tours
2015-05-01
Active, closed
ViiV Healthcare
Phase 3
371
Bordeaux, Marseille, Nantes, Paris
2015-02-23
Active, closed
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
NCT02243605Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma, Recurrent Osteosarcoma
National Cancer Institute (NCI)
Phase 2
90
Bordeaux, Dijon, Lille, Lyon, Marseille, Nice, Paris, Saint-Herblain
2014-12-19
Recruiting
Pancreatic Surgical Database
NCT02871336Pancreatic Neoplasms
Institut Paoli-Calmettes
Observational
1,500
Marseille
2014-11
Active, closed
Eli Lilly and Company
Phase 3
453
Bron, Dijon, Grenoble, Lille, Marseille, Poitiers, Rennes, Saint-Brieuc
2014-10-03
Recruiting
Centre Hospitalier Universitaire, Amiens
Phase 2
50
Amiens, Bordeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nancy
2014-09-12
Active, closed
Acerta Pharma BV
Phase 2
107
Aurillac, Clermond Ferrand, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers
2014-09-11
Recruiting
UNICANCER
Observational
42,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille
2014-07
Recruiting
Imagine Institute
Observational
1,445
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Strasbourg, Toulouse
2014-06-16
Active, closed
University Hospital, Toulouse
Observational
1,700
Bordeaux, Clichy, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2014-05
Recruiting
Chronic Myeloid Leukemia (CML) Real-Life Database
NCT05963061Chronic Myeloid Leukemia (CML)
University Hospital, Clermont-Ferrand
Observational
3,500
Annecy, Caen, Clermont-Ferrand, Le Puy-en-Velay, Limoges, Marseille, Nancy, Paris
2014-04-16
Recruiting
Boston Scientific Corporation
Observational
1,500
Créteil, Lyon, Marseille, Paris, Rennes
2014-03-04
Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
NCT02074839Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies, Myelodysplastic Syndromes
Institut de Recherches Internationales Servier
Phase 1
291
Marseille, Pessac, Pierre-Bénite, Villejuif
2014-03-01
Recruiting
Centre Leon Berard
Phase 2
900
Bordeaux, Lyon, Marseille, Paris, Strasbourg, Toulouse
2014-03
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
154
Villejuif, Avignon, Caen, Dijon, Lille, Marseille, Montpellier, Nice
2014-02-26
Active, closed
Genetix Biotherapeutics Inc.
Observational
66
Marseille, Paris
2014-01
Active, closed
Predictive Clinical and Biological Parameters in Gynecological Cancer
NCT01977274Ovarian Cancer, Endometrium Cancer, Cervix Cancer
Institut Paoli-Calmettes
Not applicable
300
Marseille
2013-12
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
112
Créteil, Dijon, Estaing, Grenoble, Lille, Lyon, Marseille, Montpellier
2013-12
Active, closed
Novartis Pharmaceuticals
Phase 1/2
259
Marseille, Paris, Saint-Herblain
2013-10-22
Active, closed
AstraZeneca
Phase 3
510
Brest, Caen, Clermont-Ferrand, Dijon, Lille, Marseille, Paris, Pierre-Bénite
2013-09-25
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Toulouse
2013-07-26
Recruiting
Pitié-Salpêtrière Hospital
Observational
800
Angers, Strasbourg, Marseille, Caen, Brest, Nîmes, Bordeaux, Toulouse
2013-07-11
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Montpellier, Nancy
2013-04
Active, closed
Centre Hospitalier Universitaire de Nice
Observational
246
Colmar, Clermont-Ferrand, Épagny, Grenoble, Lille, Limoges, Lyon, Marseille
2013-03
Active, closed
Institut Paoli-Calmettes
Not applicable
2,228
Marseille
2012-07-19
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Strasbourg, Amiens, Angers, Bordeaux, Clermont-Ferrand, Créteil, Lille, Marseille
2012-07
Active, closed
Radical Fimbriectomy for Young BRCA Mutation Carriers
NCT01608074BRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian Cancer
Centre Oscar Lambret
Not applicable
123
Aix-en-Provence, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Nice, Paris
2012-01-09
Active, closed
Vismodegib in Treating Patients With Advanced Chondrosarcomas
NCT01267955Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma, Mesenchymal Chondrosarcoma
National Cancer Institute (NCI)
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2010-12-21
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice, Lille, Marseille, Nantes, Nîmes, Paris, Poitiers, Rennes
2010-01-01
Recruiting
Institut Paoli-Calmettes
Observational
3,000
Marseille
2010-01
Recruiting
Institut Paoli Calmettes Prostate Cancer Database
NCT02869594Prostatic Neoplasms
Institut Paoli-Calmettes
Observational
10,000
Marseille
2010-01
Recruiting
Institut Paoli-Calmettes
Observational
5,000
Marseille
2010-01
Recruiting
Saint-Louis Hospital, Paris, France
Not applicable
575
Amiens, Bordeaux, Clermont-Ferrand, Clichy, Créteil, Le Kremlin-Bicêtre, Lille, Marseille
2009-12-10
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Amiens, Blois, Bondy, Bron, Clermont-Ferrand, Marseille, Montpellier, Mulhouse
2008-12-09
Active, closed
Genentech, Inc.
Phase 2
378
Caen, Dijon, Marseille, Montpellier, Paris, Saint-Cloud, Saint-Herblain
2008-10-16
Active, closed
UNICANCER
Not applicable
500
Angers, Bordeaux, Caen, Chambéry, Chambray-lès-Tours, Créteil, Lyon, Marseille
2008-10
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Marseille, Nancy, Nice, Paris, Rennes, Villejuif
2007-12
Recruiting
Institut Paoli Calmettes Chronic Lymphatic Leukemia Database
NCT02869529Leukemia, Lymphocytic, Chronic, B-Cell
Institut Paoli-Calmettes
Observational
4,200
Marseille
2006-01
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Bordeaux, Brest, Bron, Caen, La Tronche, Lille, Marseille, Nancy
2004-09-15
Recruiting
Institut Paoli Calmettes Cardia Cancer Database
NCT02869477Stomach Neoplasms, Cardia
Institut Paoli-Calmettes
Observational
2,000
Marseille
2002-01
Recruiting
Institut Paoli Calmettes Cervical Cancer Database
NCT02869490Uterine Cervical Neoplasms
Institut Paoli-Calmettes
Observational
6,000
Marseille
2002-01
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Bordeaux, Bron, Garches, Lille, Limoges, Marseille, Saint-Priest-en-Jarez, Strasbourg
2001-07-31
Recruiting
Manuel Monreal
Observational
120,000
Besançon, Brest, Clermont-Ferrand, Colombes, Dijon, Lyon, Villeurbanne, Marseille
2001-03
Recruiting
Institut Paoli Calmettes Colorectal Cancer Database
NCT02869503Colorectal Neoplasms
Institut Paoli-Calmettes
Observational
22,000
Marseille
2001-01
Recruiting
Institut Paoli-Calmettes
Observational
8,500
Marseille
2000-01
Recruiting
Institut Paoli-Calmettes
Observational
6,000
Marseille
2000-01
Recruiting
Institut Paoli-Calmettes
Observational
16,000
Marseille
2000-01
Recruiting
Institut Paoli-Calmettes
Observational
5,000
Marseille
1999-10-15
Recruiting
Institut Paoli Calmettes Acute Leukemia Database
NCT02869516Acute Leukemia Diagnosis
Institut Paoli-Calmettes
Observational
27,000
Marseille
1995-01
Recruiting
Institut Paoli Calmettes Breast Cancer Database
NCT02869607Breast Cancer Diagnosis
Institut Paoli-Calmettes
Observational
45,000
Marseille
1995-01
Rows per page Showing 1001–1288 of 1288
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-france/city/marseille?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,730 studies in total at the last sync on 20 Nov 2026, 03:21 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,288 of those studies with a site in Marseille.

How many clinical trials are recruiting in Marseille?

696 of the 1,288 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:21 UTC sync. A further 99 have not yet opened recruitment, 474 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.